Operating Lease, Right-of-Use Asset in USD of Eiger BioPharmaceuticals, Inc. from Q1 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Eiger BioPharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2019 to Q3 2023.
  • Eiger BioPharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2023 was $209K, a 15% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Eiger BioPharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $209K -$37K -15% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $329K -$56K -14.5% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $446K -$75K -14.4% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $561K -$92K -14.1% 31 Dec 2022 10-Q 09 Nov 2023
Q3 2022 $246K -$531K -68.3% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $385K -$518K -57.4% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $521K -$528K -50.3% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $653K -$523K -44.5% 31 Dec 2021 10-K 17 Mar 2023
Q3 2021 $777K -$523K -40.2% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $903K -$518K -36.5% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $1.05M -$490K -31.8% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $1.18M -$478K -28.9% 31 Dec 2020 10-K 10 Mar 2022
Q3 2020 $1.3M -$359K -21.6% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $1.42M -$340K -19.3% 30 Jun 2020 10-Q 06 Aug 2020
Q1 2020 $1.54M -$322K -17.3% 31 Mar 2020 10-Q 07 May 2020
Q4 2019 $1.65M 31 Dec 2019 10-K 09 Mar 2021
Q3 2019 $1.66M 30 Sep 2019 10-Q 07 Nov 2019
Q2 2019 $1.76M 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 $1.86M 31 Mar 2019 10-Q 09 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.